http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0518790-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a4d00d3c787d249a0e7961b08ce2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6128a6d4aa2c088229d6013532350ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e61be5272ada83358044ab4a50bee2ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1264cf0c2c19047ddd5d7c449ce556c
publicationDate 2008-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0518790-A2
titleOfInvention pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet
abstract PHARMACEUTICAL FORMULATION, PROCESS FOR PREPARING PHARMACEUTICAL FORMULATION, PRODUCT, AND CAPSULE OR TABLET. The present invention provides benzoxazole solid dosage formulations containing ERB-selective binders, and processes for their manufacture.
priorityDate 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407625565

Total number of triples: 32.